報價延遲最少15分鐘:2025/02/23 04:41 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
22.48 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.48/1.24
|
|
企業價值
1.42B
|
| 資產負債 |
|
每股賬面淨值
6.09
|
| 現金流量 |
|
現金流量率
0.06
|
| 損益表 |
|
收益
1.02B
|
|
每股收益
24.14
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/23 04:41 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture.The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries. |